Who owns Cetraben?
Cetraben is owned by STADA (Germany), which has owned the brand since 2011.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: STADA's strong growth journey continues in 2025, STADA Arzneimittel AG, 18 March 2026. Last checked .
Key facts
- Current owner
- STADA Arzneimittel AG reported
- Owned since
- Owner HQ
- 🇩🇪 Germany, Bad Vilbel
- Origin
- 🇬🇧 United Kingdom
- Category
- Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
- Last verified
- · 3 sources
About Cetraben
Cetraben is a British range of emollients for dry, sensitive and eczema-prone skin, sold as a cream, lotion, ointment, bath additive, oatmeal cream and facial cleanser, several of them registered as medical devices. STADA's company history records its acquisition of the British branded product Cetraben in 2011, two years before it bought the Huddersfield OTC maker Thornton & Ross. STADA lists Cetraben among the derma brands of its consumer health business.
Ownership timeline of Cetraben
Where Cetraben sits in STADA
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full STADA ownership tree →
See the full STADA brand portfolio (6) →
Other brands owned by STADA
STADA controls 6 brands on Brandtree, 2 of them in personal care & beauty.
Also in personal care & beauty
Other brands in dermocosmetics & clinical skin care, and who owns them
The 48 brands in dermocosmetics & clinical skin care on Brandtree belong to 27 owners. The largest is Ego Pharmaceuticals, with 9.
| Brand | Owner | Owner based in |
|---|---|---|
| DermAid | Ego Pharmaceuticals | 🇦🇺 Australia |
| Biretix | Cantabria Labs | 🇪🇸 Spain |
| CeraVe | L'Oréal | 🇫🇷 France |
| A-Derma | Pierre Fabre | 🇫🇷 France |
| Dermalogica | Unilever | 🇬🇧 United Kingdom |
| Minon | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Alastin | Galderma | 🇨🇭 Switzerland |
| REALBARRIER | Neopharm | 🇰🇷 South Korea |
Every brand in dermocosmetics & clinical skin care and its owner →
About the owner: STADA
STADA is a privately held company headquartered in Bad Vilbel, Germany, founded in 1895. Brandtree records 6 brands under its control.
STADA Arzneimittel AG is a German maker of consumer health products, generic medicines and specialty pharmaceuticals, based in Bad Vilbel, Hesse, that sells in more than 100 countries. It traces its roots to a pharmacists' association formed in Dresden in 1895 to make shared preparations, and it stayed a cooperative until it became a corporation in 1970. Bain Capital and Cinven took it over in 2017, and a squeeze-out in November 2020 left all its shares with the holding company Nidda Healthcare. CapVest completed the purchase of their majority stake on 31 March 2026, with both firms keeping minority stakes. STADA's group sales in 2025 were €4,296 million, with 11,749 employees.
🇬🇧 Cetraben and other British brands
Brandtree records a controlling owner for 570 brands that began in the United Kingdom. 297 of them (52%) are now controlled by a company headquartered in another country, Cetraben among them.
- Andrex — Kimberly-Clark 🇺🇸
- Batiste — Church & Dwight 🇺🇸
- Charlotte Tilbury — Puig 🇪🇸
- Childs Farm — PZ Cussons 🇬🇧
- Creed — L'Oréal 🇫🇷
- Cushelle — Essity 🇸🇪
Frequently asked questions
Who is the parent company of Cetraben?
The parent company of Cetraben is STADA, a privately held company headquartered in Germany.
Is Cetraben British or German?
Cetraben originated in the United Kingdom, but it is owned today by STADA, which is headquartered in Germany. So Cetraben is a British-origin brand under German ownership.
Since when has STADA owned Cetraben?
STADA has owned Cetraben since 2011.
Is Cetraben still owned by STADA?
Yes. As of 24 October 2026, Cetraben is still owned by STADA. The ownership record was last checked against primary sources on that date.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] STADA's strong growth journey continues in 2025 — STADA Arzneimittel AG, Official press release, published 18 March 2026; retrieved 24 October 2026.
- [2] STADA — Cetraben — STADA Arzneimittel AG, Official document; retrieved 24 October 2026.
- [3] STADA — Company history — STADA Arzneimittel AG, Official document; retrieved 24 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.